Drug profile · INN
pegfilgrastim-bmez
ZIEXTENZO
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
pegfilgrastim-bmez (ZIEXTENZO) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN pegfilgrastim-bmez
Brand ZIEXTENZO
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is pegfilgrastim-bmez?
pegfilgrastim-bmez (ZIEXTENZO) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for pegfilgrastim-bmez?
ZIEXTENZO is a marketed brand name for pegfilgrastim-bmez. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pegfilgrastim-bmez?
pegfilgrastim-bmez has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.